Wells Fargo
LEXX icon

Wells Fargo’s Lexaria Bioscience LEXX Stock Holding History

Wells Fargo’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,000
Closed -$1.74K – 7258
2025
Q2 		$1.74K Hold
2,000
– – ﹤0.01% 6230
2025
Q1 		$3.42K Sell
2,000
-2,000
-50% -$3.39K ﹤0.01% 6086
2024
Q4 		$8.4K Buy
4,000
+1,500
+60% +$3.69K ﹤0.01% 5973
2024
Q3 		$7.63K Sell
2,500
-800
-24% -$2.54K ﹤0.01% 5853
2024
Q2 		$9.17K Buy
3,300
+2,227
+208% +$6.68K ﹤0.01% 5765
2024
Q1 		$3.9K Buy
1,073
+11
+1% +$28 ﹤0.01% 5932
2023
Q4 		$1.33K Sell
1,062
-24
-2% -$31 ﹤0.01% 6163
2023
Q3 		$1.09K Buy
1,086
+15
+1% +$14 ﹤0.01% 6182
2023
Q2 		$782 Buy
1,071
+2
+0.2% +$3 ﹤0.01% 6383
2023
Q1 		$2.91K Buy
1,069
+34
+3% +$97 ﹤0.01% 6171
2022
Q4 		$2.55K Buy
1,035
+1
+0.1% +$2 ﹤0.01% 5953
2022
Q3 		$2K Buy
1,034
+2
+0.2% +$6 ﹤0.01% 6160
2022
Q2 		$3K Buy
1,032
+2
+0.2% +$5 ﹤0.01% 6190
2022
Q1 		$3K Buy
1,030
+5
+0.5% +$19 ﹤0.01% 6585
2021
Q4 		$4K Buy
1,025
+1,000
+4,000% +$5.69K ﹤0.01% 6755
2021
Q3 		$0 Sell
25
-4
-14% -$26 ﹤0.01% 7270
2021
Q2 		$0 Hold
29
– – ﹤0.01% 7187
2021
Q1 		$0 Buy
+29
New +$170 ﹤0.01% 7154

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo's LEXX Position: Q3 2025 in Review

Wells Fargo sold out of Lexaria Bioscience (LEXX) in Q3 2025, closing a stake of 2,000 shares — an estimated $1.74K sold.

Wells Fargo first reported a position in LEXX in Q1 2021 and held it in 18 quarters. The position peaked at $9.17K in Q2 2024. 25 funds tracked by Wall St. Rank hold LEXX as of Q3 2025.

  • Wells Fargo reported no remaining Lexaria Bioscience position as of Q3 2025 after selling out during the quarter.
  • Wells Fargo sold 2,000 Lexaria Bioscience shares in Q3 2025, an estimated $1.74K.
  • Wells Fargo first reported a position in Lexaria Bioscience in Q1 2021 and held it in 18 quarters.
  • Wells Fargo's Lexaria Bioscience position peaked at $9.17K in Q2 2024.
  • 25 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q3 2025.

Based on Wells Fargo's 13F filing for Q3 2025, filed 13 Nov 2025.